Literature DB >> 2183713

Amphotericin B: current understanding of mechanisms of action.

J Brajtburg1, W G Powderly, G S Kobayashi, G Medoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2183713      PMCID： PMC171553          DOI： 10.1128/AAC.34.2.183

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  53 in total

1.  Lipid composition and polyene antibiotic resistance of Candida albicans mutants.

Authors:  A M Pierce; H D Pierce; A M Unrau; A C Oehlschlager
Journal:  Can J Biochem       Date:  1978-02

2.  Sterols from polyene-resistant mutants of Candida albicans.

Authors:  J M Hamilton-Miller
Journal:  J Gen Microbiol       Date:  1972-11

3.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

4.  Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.

Authors:  D P Bonner; R P Tewari; M Solotorovsky; W Mechlinski; C P Schaffner
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

5.  Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function.

Authors:  D J Drutz; R I Lehrer
Journal:  Am J Med Sci       Date:  1978 Jul-Aug       Impact factor: 2.378

6.  Eburicol, lichesterol, ergosterol, and obtusifoliol from polyene antibiotic-resistant mutants of Candida albicans.

Authors:  R E Subden; L Safe; D C Morris; R G Brown; S Safe
Journal:  Can J Microbiol       Date:  1977-06       Impact factor: 2.419

7.  Development of resistance to amphotericin B in Candida lusitaniae infecting a human.

Authors:  D Pappagianis; M S Collins; R Hector; J Remington
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.

Authors:  L I Lutwick; J N Galgiani; R H Johnson; D A Stevens
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

9.  Isolation and characterization of a polyene-resistant variant of Candida tropicalis.

Authors:  W G Merz; G R Sandford
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

10.  Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles.

Authors:  J Milhaud; M A Hartmann; J Bolard
Journal:  Biochimie       Date:  1989-01       Impact factor: 4.079
View more
  121 in total

1.  Molecular dynamics simulation of the structure of dimyristoylphosphatidylcholine bilayers with cholesterol, ergosterol, and lanosterol.

Authors:  A M Smondyrev; M L Berkowitz
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

Review 2.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

3.  Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Authors:  Bidyut Purkait; Ashish Kumar; Nilay Nandi; Abul Hasan Sardar; Sushmita Das; Sudeep Kumar; Krishna Pandey; Vidyananda Ravidas; Manish Kumar; Tripti De; Dharmendra Singh; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.

Authors:  M A Moreno; P Frutos; M P Ballesteros
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

5.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Universal behavior of membranes with sterols.

Authors:  J Henriksen; A C Rowat; E Brief; Y W Hsueh; J L Thewalt; M J Zuckermann; J H Ipsen
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

8.  A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.

Authors:  Daniel S Palacios; Thomas M Anderson; Martin D Burke
Journal:  J Am Chem Soc       Date:  2007-10-23       Impact factor: 15.419

9.  Enhancement of amphotericin B activity against Candida albicans by superoxide radical.

Authors:  Yuichi Okamoto; Shigeji Aoki; Izumi Mataga
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

10.  Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.

Authors:  Cristiana T Trinconi; Juliana Q Reimão; Jenicer K U Yokoyama-Yasunaka; Danilo C Miguel; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.